College of Animal Science and Technology, Anhui Agricultural University, Hefei, 230036, China.
College of Biological and Pharmaceutical Engineering, West Anhui University, Lu'an, 237012, China.
Curr Drug Metab. 2021;22(12):957-968. doi: 10.2174/1389200222666211029145512.
Carbonized herbal medicine has been used clinically for centuries in China; however, its influence on the bioavailability of compatible medicinal herbs is still unknown.
To explore the effect of a carbonized herbal medicine on the in vivo adsorption and release and absorption of other active pharmaceutical ingredients in a compound prescription.
The bioavailability of carbonized Herba schizonepetae (CHS) to eight active components (epiberberine, coptisine, palmatine, berberine, phellodendrine, aesculin, aesculetin, and anemoside B4) in the aqueous extract of Pulsatillae Decoction (PDAE) was evaluated by the in vitro adsorption and release and in vivo pharmacokinetics tests. Activated carbon (AC) was used as the control.
In vitro experiment showed that the cumulative adsorption rates of CHS to the eight active components were 33.17%, 54.32%, 21.48%, 42.01%, 39.1%, 25.11%, 32.11%, and 23.08% which was characterized by copsitine > berberine > phellodendrine > epiperberine > aesculetin > anemoside B4 > palmatine., and they were significantly lower than those of AC. The stable release concentration in sequence was 3.23, 3.04, 3.32, 7.29, 3.17, 2.80, 1.45, and 3.81 μg/mL, which was characterized by berberine > anemoside B4 > palmatine > epiberberine > phellodendrine > coptisine > aesculin > aesculetin, and they were significantly higher than those of AC. The animal experiment indicated that the areas under the concentration-time curve (AUC0-∞) of epiberberine, berberine, aesculetin, and anemoside B4 in PDAE+CHS group were significantly higher than those in the PDAE and PDAE+AC groups, and the other four components in the PDAE+CHS group were lower than those in PDAE group but higher than those in PDAE+AC group.
CHS could significantly improve the bioavailability of epiberberine, berberine, aesculetin, and anemoside B4 in Pulsatillae Decoction and has a sustained-release effect on berberine, aesculin, aesculetin, and anemoside B4.
在中国,药用炭化植物已经有几个世纪的临床应用历史,但它对复方中其他药用植物的生物利用度的影响仍不清楚。
探索药用炭化荆芥对复方中其他活性药物成分的体内吸附、释放和吸收的影响。
采用体外吸附-释放和体内药代动力学试验,评价药用炭化荆芥(CHS)对白头翁汤水提物(PDAE)中 8 种活性成分(盐酸小檗碱、盐酸黄连碱、盐酸巴马汀、盐酸黄柏碱、盐酸黄芩苷、秦皮甲素、秦皮乙素和毛蕊花糖苷)的生物利用度。以活性炭(AC)为对照。
体外实验表明,CHS 对 8 种活性成分的累积吸附率分别为 33.17%、54.32%、21.48%、42.01%、39.1%、25.11%、32.11%和 23.08%,其特征为盐酸黄连碱>盐酸小檗碱>盐酸黄柏碱>盐酸黄柏碱>盐酸黄芩苷>秦皮甲素>毛蕊花糖苷,显著低于 AC;稳定释放浓度分别为 3.23、3.04、3.32、7.29、3.17、2.80、1.45 和 3.81μg/ml,其特征为盐酸小檗碱>毛蕊花糖苷>盐酸巴马汀>盐酸黄柏碱>盐酸黄连碱>秦皮甲素>秦皮乙素>秦皮乙素,显著高于 AC。动物实验表明,PDAE+CHS 组中盐酸小檗碱、盐酸小檗碱、秦皮乙素和毛蕊花糖苷的浓度-时间曲线下面积(AUC0-∞)均显著高于 PDAE 组和 PDAE+AC 组,而 PDAE+CHS 组中的其他 4 种成分均低于 PDAE 组,但高于 PDAE+AC 组。
药用炭化荆芥能显著提高白头翁汤中盐酸小檗碱、盐酸小檗碱、秦皮乙素和毛蕊花糖苷的生物利用度,并对盐酸小檗碱、秦皮苷、秦皮乙素和毛蕊花糖苷具有持续释放作用。